Benzinga | Mar 4, 2021 04:15PM EST

Fulgent Genetics Q4 EPS $6.20 Beats $4.05 Estimate, Sales $295.00M Beat $199.44M Estimate

Fulgent Genetics (NASDAQ:FLGT) reported quarterly earnings of $6.20 per share which beat the analyst consensus estimate of $4.05 by 53.09 percent. This is a 15400 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $295.00 million which beat the analyst consensus estimate of $199.44 million by 47.91 percent. This is a 3.42K percent increase over sales of $8.39 million the same period last year.